Director – Technology Business Operations
About the job
- 12+ years of IT experience, including 4+ years leading IT strategy for a fast-growing company, covering value assessments, prioritization frameworks, multi-year planning, and judgment in scaling technology investment alongside the business.
- Familiarity with Technology Business Management (TBM) or a comparable technology operating model for governing spend, portfolio, and value.
- Experience partnering with FP&A, Procurement/Legal, Enterprise Architecture, and cross-functional stakeholders without owning their processes.
- Executive-level communication skills, including owning how the department presents itself upward and outward.
- Ability to build strategic planning, financial, and governance processes from scratch in a cross-functional environment, and to operate hands-on as the sole builder and manager of a small team before it scales to FTEs.
- Ability to maintain scope as the strategic and prioritization layer without taking on architecture, delivery, or platform ownership belonging to other functions.
- Daily use of LLM assistants or agents (such as Claude) for research, drafting, analysis, and problem-solving, with judgment about appropriate use and verification of outputs.
- Ability to identify recurring processes suitable for AI-assisted work and incorporate that approach into team workflows.
- Own IT's strategic planning, prioritization, and governance layer while architecture, delivery, data platforms, cloud infrastructure, and AI enablement remain with their existing teams.
- Manage a two-resource contractor bridge during the build-out, then hire, lead, and develop a target-state team of two to three full-time employees.
- Build IT's annual planning cycle, multi-year technology plan, business cases, and investment narratives to support funding and prioritization decisions.
- Establish a visible prioritization and governance model for IT work and decision-making.
- Own financial operations in partnership with FP&A, including the cost-center model, contractor versus FTE spend, named application ownership, forecast inputs, and consolidated IT spend and renewal exposure; provide inputs to FP&A's monthly variance review without becoming a purchasing approval gate.
- Own procurement, contract, and renewal management, including a renewal calendar, negotiation packets, and an application inventory with a named service owner per application.
- Administer contractor and SOW processes and workforce operations, including requisition tracking and onboarding readiness across multiple countries.
- Run IT's executive operating cadence, including all-hands, monthly updates, quarterly roadmap reviews, IT Leadership team meetings, and business reviews.
Our mission at Oura is to empower every person to own their inner potential. Our award-winning products help our global community gain a deeper knowledge of their readiness, activity, and sleep quality by using their Oura Ring and its connected app. We've helped millions of people understand and improve their health by providing daily insights and practical steps to inspire healthy lifestyles.
Empowering the world starts with living our values and empowering our team. As a quickly growing company focused on helping people live healthier and happier lives, we ensure that our team members have what they need to do their best work — both in and out of the office.
We are looking for a Director, Technology Business Operations to build and lead IT's strategic planning, prioritization, and financial governance function from the ground up. You'll give Oura's roughly 70-person IT organization — spanning about 300 applications — a shared way to plan, prioritize, and see its own spend, replacing work that today happens informally at leadership cost. You'll start as the sole builder, then manage and grow a small team — beginning with a contractor bridge — as the work proves it out.
What You Will Do:
- Own the strategic layer for IT — value-based planning, prioritization, and governance — while architecture, delivery, data platforms, cloud infrastructure, and AI enablement stay with the teams that already own them
- Manage a contractor bridge of two resources (Portfolio Manager, Analyst) through build-out, then hire, lead, and develop a target-state team of 2–3 FTEs (Analyst, Portfolio Manager, Strategist)
- Build IT's strategic planning system: the annual planning cycle, the multi-year technology plan, and the business cases and investment narratives that justify what gets funded and in what order
- Stand up a shared, visible prioritization and governance model for what IT works on and why, so decisions aren't made informally or re-litigated team by team
- Own financial operations in partnership with FP&A — cost-center model, contractor vs. FTE spend, named application ownership, forecast inputs, and a consolidated view of total IT spend and renewal exposure across a technology budget in the upper tens of millions of dollars — feeding FP&A's monthly variance review without becoming a purchasing approval gate
- Own procurement, contract, and renewal management, building a renewal calendar, negotiation packets, and an application inventory with a named service owner per app
- Own contractor and SOW administration and workforce operations — requisition tracking and onboarding readiness across multiple countries
- Run IT's executive operating cadence — all-hands, monthly updates, quarterly roadmap reviews, IT Leadership team meetings, business reviews — as a system that runs without last-minute assembly
This is a hybrid role out of our San Francisco office.
What you'll bring
- 12+ years of IT experience, including 4+ years leading IT strategy for a fast-growing company — value assessments, prioritization frameworks, multi-year planning, and the judgment calls that come with scaling technology investment alongside the business
- Strong operational discipline, with familiarity with Technology Business Management (TBM) or a comparable technology operating model for governing spend, portfolio, and value
- Experience partnering with FP&A, Procurement/Legal, Enterprise Architecture, and cross-functional stakeholders without owning their process
- Exceptional executive-level communication skills — you'll own how the department presents itself upward and outward; this is an explicit screen, not a nice-to-have
- Demonstrated ability to build strategic planning, financial, and governance processes from scratch in a cross-functional environment, and comfortable operating as the hands-on, sole builder and manager of a small team (starting with a contractor bridge) before it scales to FTEs
- Clarity and discipline about scope: able to operate as the strategic/prioritization layer without drifting into architecture, delivery, or platform ownership that belongs to other functions
- Use LLM assistants/agents (e.g., Claude) daily in your work — research, drafting, analysis, problem-solving — with judgment about when AI is and isn't the right tool, and a habit of verifying output
- Bring judgment to identify which of your own function's recurring processes (renewal tracking, planning-artifact assembly, spend consolidation, reporting) should shift from manual to AI-assisted work, and build that into your team's workflows — not just your own tasks
Benefits
At Ōura, we care about you and your well-being. Everyone here at Ōura has a ring of their own and we are continually looking to improve employee health.
What we offer:
- Competitive salary and equity packages
- Health, dental, vision insurance, and mental health resources
- An Ōura Ring of your own plus employee discounts for friends & family
- 20 days of paid time off plus 13 paid holidays plus 8 days of flexible wellness time off
- Paid sick leave and parental leave
Ōura takes a market-based approach to pay, which may vary depending on your location. US locations are categorized into tiers based on a cost of labor index for that geographic area. While most offers will be closer to the starting range, successful candidates' pay will be determined based on job-related skills, experience, qualifications, work location, internal peer equity, and market conditions. These ranges may be modified in the future.
Region 1 $200,600 - $236,000
Region 2 $182,750 - $215,000
Region 3 $164,900 - $194,000
A recruiter can determine your Region based on your US location.
We are not considering candidates residing in the following states: Alaska (AK), Delaware (DE), Iowa (IA), Mississippi (MS), Nebraska (NE), South Dakota (SD), West Virginia (WV), and Wisconsin (WI).
Oura is proud to be an equal opportunity workplace. We celebrate diversity and are committed to creating an inclusive environment for all employees. Individuals seeking employment at Oura are considered without regard to age, ancestry, color, gender (including pregnancy, childbirth, or related medical conditions), gender identity or expression, genetic information, marital status, medical condition, mental or physical disability, national origin, protected family care or medical leave status, race, religion (including beliefs and practices or the absence thereof), sexual orientation, military or veteran status, or any other characteristic protected by federal, state, or local laws. We will not tolerate discrimination or harassment based on any of these characteristics.
We will work to ensure individuals with disabilities are provided reasonable accommodation to participate in the interview process, to perform essential job functions, and to receive other benefits and privileges of employment.
Disclaimer: Beware of fake job offers!
We’ve been alerted to scammers posing as ŌURA recruiters, especially for remote roles. Please note:
- Our jobs are listed only on the ŌURA Careers page and trusted job boards.
- We will never ask for personal information like ID or payment for equipment upfront.
- Official offers are sent through Docusign after a verbal offer, not via text or email.
Stay cautious and protect your personal details.
To all recruitment agencies: Oura does not accept agency resumes. Please do not forward resumes to our jobs alias, Oura employees, or any other organization's location. Oura is not responsible for any fees related to unsolicited resumes.
About the company
Oura designs smart rings and a companion app for people who want to understand their sleep, activity, stress, and recovery. Its ring measures signals such as heart rate, movement, and temperature while fitting into daily life without a screen on the wrist. The app turns these daily measurements into sleep and readiness scores, compares changes with a personal baseline, and suggests habits that support rest and activity. Oura sells rings through its website and retail partners, while paid memberships unlock detailed app insights and guidance beyond the basic scores. Founded in Finland in 2013, Oura is headquartered in San Francisco, United States.
Company Size
1,001-5,000
Company Stage
Series E
Total Funding
$1.5B
Headquarters
Oulu, Finland
Founded
2013
Get referred to Oura
See people who can refer or advise you
Simplify's Take
What believers are saying
- Oura funded expansion: its October 2025 Fidelity-led round raised over $900 million for distribution and product development.
- Paid memberships persist: Oura's weighted-average twelve-month retention reached 85% by June 2026.
- Oura's California teams get recovery time: San Francisco and San Diego benefits include eight flexible wellness days.
What critics are saying
- Oura remains hardware dependent: ring sales generated 83% of fiscal 2025 revenue.
- Oura's illness alerts have limits: Health Radar is for wellness and expressly excludes disease diagnosis or treatment.
- Oura's sensor testing requires lab presence: its San Francisco engineer listing specifies onsite work and collaboration across time zones.
What makes Oura unique
- Oura houses its own scientific bench: more than 50 PhDs work in an interdisciplinary science team.
- Oura connects nighttime data to contraception: Natural Cycles analyzes its temperature trends through a separate birth control subscription.
- Oura licenses its smart ring inventions: its patent portfolio includes a multiyear agreement with rival Circular.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Competitive salary & equity packages
- Health, dental, financial, & vision insurance
- Wellness & mental health benefits
- $300 per month health improvement related stipend
- Flexible working hours
- An Oura Ring of your own
- Employee discount for friends & family
- 20 days of PTO
Growth & Insights and Company News
6 month growth
8%1 year growth
7%2 year growth
0%Department of Health - Abu Dhabi and ŌURA launch research partnership to study early warning signs of premature birth. October 20, 2026 at 23:00 PM EDT i This article is third-party content and does not represent the views of this site. Tamar Securities, LLC make no guarantees regarding its accuracy or completeness. * Project CRADLE is a first-of-its-kind 24-month pilot study that will examine whether continuous wearable data can help predict spontaneous premature birth * The study will lay the groundwork for predictive models that health systems could use to improve outcomes for mothers and babies Department of Health - Abu Dhabi (DoH) and ŌURA, a leading health intelligence platform and maker of the world's smallest smart ring, today announced Project CRADLE (Capturing Risk And Detecting Labor signals in Elevated-risk pregnancies), a 24-month pilot study to research how biometric data from wearable technology can reveal early warning signs of spontaneous premature birth. From Left to Right: H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health - Abu Dhabi, ŌURA CEO Tom Hale, and H.E. Mansoor Al Mansoori Chairman of the Department of Health - Abu Dhabi Announced by H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health - Abu Dhabi and ŌURA CEO Tom Hale at the Abu Dhabi Future Health Summit, Project CRADLE is the first live research initiative in the long-term partnership between DoH and ŌURA, previously announced in May 2026, to study how continuous wearable data can advance preventative health. Premature, or preterm, birth is when a baby is born before 37 completed weeks of pregnancy, and can occur spontaneously or following medical intervention. It affects roughly 1 in 10 births worldwide, accounting for millions of births every year, and remains one of the most unpredictable complications in pregnancy. Today, clinicians largely rely on symptoms and medical history, but identifying risks earlier in pregnancy could allow care teams to intervene sooner, ensure families are within reach of the right care, and help protect the health of mothers and babies. Project CRADLE will combine continuous wearable data from Oura Ring with Abu Dhabi's clinical and genomic data to better understand risk factors around preterm birth. Underpinned by robust data governance, clear ethics approvals and rigorous clinical oversight, this jointly designed study aims to set a structured path from research to real-world application within healthcare systems, including broader integration within Abu Dhabi's health system, subject to evidence and regulatory approval. The initial healthcare institutions to participate in the pilot will be Corniche Hospital and Mediclinic Airport Road, two of the leading maternal care institutions in Abu Dhabi. "In Abu Dhabi, we are building an intelligent health system of the future," said H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health - Abu Dhabi. "Continuous sensing enables a shift from reactive care to healthcare that anticipates risk, detects warning signs sooner, and enables faster, more precise and personalised intervention. Project CRADLE brings this approach to pregnancy and birth, one of the most pivotal moments in life, building the evidence to guide more timely care." She continued, "Women's health and fertility are at the heart of Abu Dhabi's health priorities. Our ambition is to become a leading center for reproductive health that is grounded in research that advances care. In the UAE's Year of the Family, we're proud that research carried out in Abu Dhabi could improve lives for mothers, babies, and families here and around the world." "For more than a decade, ŌURA has pioneered the science of what continuous physiological data can reveal about a person's health," said Tom Hale, CEO of ŌURA. "Project CRADLE shows what could be possible when a forward-thinking health system combines clinical excellence with accurate, continuous monitoring. We're proud to work alongside a health authority setting that standard, improving outcomes for families in the Emirate, and creating pathways that can be used across the world to improve health." Five months after signing their Memorandum of Understanding (MoU), DoH and ŌURA have moved from vision to active research, delivering on their commitment to pilot design, ethics approval, and local evidence generation. Project CRADLE is the first of three pilots focused on preventative health research, with a primary focus on women's health and cardiometabolic health. It is part of Abu Dhabi's prevention-led, data-driven health agenda which brings together Abu Dhabi's intelligent health system, population-scale health and genomics data, integrated health infrastructure, and policy to accelerate population health research, where new models of care can be safely designed, validated, and scaled. About Project CRADLE Population-level research suggests that biometrics such as heart rate and heart rate variability shift in the weeks before delivery. Project CRADLE is designed to test whether such shifts can be detected for an individual woman. The study will commence in the coming weeks and will follow an Abu Dhabi-based sample of women with elevated-risk pregnancies who choose to wear Oura Ring from early pregnancy through delivery. During the study, Oura Ring will continuously track biometrics, such as heart rate, heart rate variability, sleep and activity, which researchers will pair with clinical outcomes to build a longitudinal, labeled dataset. The study will investigate whether a reliable physiological signal appears before spontaneous preterm labor in an individual woman. It will also assess whether that signal could define a clinically actionable threshold - early enough for care teams to give treatments that support improved baby outcomes, such as lung and brain health, or to arrange transfer to specialist neonatal care. The jointly designed research will be conducted as an IRB-approved study, within DoH's data governance and Trusted Research Environment framework, with participants' informed consent and standard clinical care throughout. ŌURA's team of more than 50 in-house M.D.s and Ph.D.s will lead the wearable data science and analysis. ŌURA will partner with multiple leading health providers in Abu Dhabi to run the study, including Corniche Hospital and Mediclinic Airport Road, enabling participant recruitment alongside providing the highest level of care. Results are expected to be published in 2028. About the Department of Health -Abu Dhabi (DoH): The Department of Health - Abu Dhabi is the regulative body of the healthcare sector in the Emirate of Abu Dhabi. Committed to ensuring excellence in healthcare, DoH monitors the health status of the population while shaping the regulatory framework for the health system. This includes inspecting against regulations, enforcing standards and encouraging the adoption of world-class best practices and performance targets by all healthcare providers in the Emirate. Abu Dhabi remains dedicated to shaping the future of healthcare by establishing an intelligent and sustainable ecosystem that prioritises health, longevity and quality of life for all community members. Leveraging state-of-the-art infrastructure and cutting-edge capabilities, DoH continues to develop and implement initiatives and programmes in line with its strategic focus areas, Healthy Population, Best-in-Class Care and Resilience and Innovation. These efforts reflect DoH's unwavering commitment to predicting, preventing and personalising healthcare for every individual. For further information on DOH, visit https://www.doh.gov.ae/ and follow on X, Instagram, Facebook, LinkedIn and YouTube. About ŌURA ŌURA is a health intelligence platform designed to transform how people understand and manage their health in everyday life. ŌURA's platform is anchored by Oura Ring, the world's leading smart ring that helps you live healthier, longer. ŌURA supports millions of members worldwide across sleep, activity, stress, readiness, women's health, metabolic health, and heart health. Scientifically validated against medical gold standards, the lightweight Oura Ring tracks 50+ health metrics continuously, empowering both individuals and thousands of research teams, healthcare providers, sports teams, and organizations. Trusted by an ecosystem of more than 1,200 partners, ŌURA is advancing the future of preventative health with privacy and security at the forefront. Founded in Finland in 2013, ŌURA is headquartered in San Francisco with E.U. headquarters in Oulu, Finland. Contacts. Media contacts DoH: Mariam Al Marzooqi, +971 50 536 6660 Report this content If you believe this article contains misleading, harmful, or spam content, please let Tamar Securities, LLC know.
How product innovation keeps startups competitive: lessons from Oura's smart ring strategy. In the fast-moving world of wearable technology, standing still means falling behind. Oura, the smart ring manufacturer that once dominated its market, is discovering this truth as new competitors like RingConn and Ultrahuman circle closer. Their response? Double down on innovation with new fitness metrics that give users deeper insights into how their workouts impact their bodies. For African founders building in the health tech, IoT, and consumer hardware spaces, Oura's strategy offers a masterclass in competitive differentiation - and a warning about what happens when you assume market dominance is permanent. The competition is getting fierce. Oura didn't invent the smart ring category, but they perfected it. For years, they enjoyed a comfortable lead with minimal real competition. However, the market's growth has attracted ambitious rivals with their own innovations and often lower price points. This is a pattern FundNaija, Inc. is seeing across African tech markets too: early movers gain traction, but newer entrants challenge them with better features, local pricing, or superior user experience. Oura's response - launching advanced workout tracking features - isn't just about adding bells and whistles. It's about creating sticky value that keeps customers loyal and justifies premium pricing in an increasingly crowded marketplace. Why continuous innovation matters for your startup. Whether you're building a fintech app, health tech platform, or any software product, Oura's playbook applies: * Listen to your users: New fitness metrics came from understanding what customers actually wanted to track * Differentiate on depth, not just features: It's not enough to have fitness tracking - Oura went deeper with insights about workout impact * Move faster than competitors: In crowded markets, speed to innovation is a competitive moat * Communicate the value: New features only matter if customers understand why they should care Why this matters for founders. If you're building a startup - especially in hardware, health tech, or consumer products - remember that your first-mover advantage has an expiration date. The founders who win long-term are those who treat innovation as continuous, not occasional. This means: Building a product roadmap based on real customer feedback, investing in R&D even when business is good, and staying obsessed with solving customer problems better than anyone else. As you scale and seek funding, investors want to see that your team has a clear innovation strategy. On FundNaija, when you build your founder profile and track your growth metrics, highlighting your product development velocity and customer feedback loops can significantly strengthen your pitch to potential investors and lenders. The bigger picture. Oura's situation also reflects a broader market truth: as categories mature and attract competition, the winners are those who can evolve faster than their challengers. For African startups entering global markets or building for local needs, this is your competitive advantage - agility and the ability to move quickly based on real market feedback. Want to check your funding readiness? Try FundNaija's free FundScore to see how investor-ready your startup is and get personalized recommendations for strengthening your pitch. Get funding-ready today. Create an AI-powered business plan and discover funding opportunities tailored to your business.
Oura adds two new cardiovascular health tracking features to its smart rings. * The Verge By Andrew LiszewskiOct 20, 2026, 4:26 pm90 ptsTrending Oura is introducing two new cardiovascular-focused health tracking features to its smart rings designed to help users better understand the effect regular workouts and exercise are having on their long-term health, and whether they need to ramp it up or dial things down. Cardio Effort and automatic VO2 Max... Read Article Share Article * email * x.com * facebook * pocket * reddit * tumblr * linkedin * pinterest Tech News Tube is a real time news feed of the latest technology news headlines. Follow all of the top tech sites in one place, on the web or your mobile device.
Oura adds new fitness metrics to show how workouts impact your body | TechCrunch. As competition in the smart ring market escalates, Oura is introducing two new features to give people more insight into their workouts and how they impact their bodies. The company announced on Tuesday it's rolling out Cardio Effort and VO[2] max metrics to expand workout tracking beyond exercise duration and heart rate zones. While Oura has largely dominated the smart ring market for years, rivals like RingConn and Ultrahuman are emerging to dethrone it, putting pressure on the company to keep innovating. By launching more advanced workout metrics, Oura is looking to differentiate itself from competitors. With Cardio Effort, users will be able to see how much a workout taxes their cardiovascular system. This measurement is aggregated over the week relative to each user's individual baseline to provide more insights. Oura explained that this metric shifts users' focus from "How many minutes did I move?" to "Am I maintaining my fitness, building it, or overdoing it?" Since Cardio Effort accounts for both intensity and duration, a shorter, more intense workout can yield a similar score to a longer, less intense one, the company says. Oura notes that the metric has two components: Workout Cardio Effort and Weekly Cardio Effort. The first metric evaluates the impact of an individual workout, while the latter aggregates effort into a weekly total, categorized as "Light," "Fair," "Maintaining," "Building," or "Reaching." Oura measures elevated heart rate relative to each member's long-term resting heart rate, avoiding the variability associated with maximum-heart-rate estimates. Weekly effort levels are then determined using personalized ranges based on recent activity patterns. Cardio Effort is rolling out to Oura Ring Gen3 and later models. As for VO[2] max, the metric shows how workouts contribute to long-term fitness. It measures how effectively the heart, lungs, and muscles work together to deliver and use oxygen during exercise. Previously, measuring VO[2] max typically required a lab test or a six-minute walking test. Oura can now estimate it passively using GPS-enabled workouts. After completing five qualifying activities, users receive an initial VO2 Max estimate. Within the My Health Heart Hub, they can view their current VO2 Max estimate in ml/kg/min, their fitness category (Low, Fair, High, or Peak), how their estimate has changed over time, and when it was last updated. Users also receive insights highlighting meaningful changes in their VO2 Max or indicating when their estimate remains consistent. VO[2] Max is launching in Oura Labs, the company's hub for experimental features, for members with Gen3 and newer Oura Ring devices. Oura says these two new features are designed to work together to show users how hard they're working and how that effort is adding up over time. When you purchase through links in its articles, Egerin Inc. may earn a small commission. This doesn't affect its editorial independence. Aisha is a consumer news reporter at TechCrunch. Prior to joining the publication in 2021, she was a telecom reporter at MobileSyrup. Aisha holds an honours bachelor's degree from University of Toronto and a master's degree in journalism from Western University. You can contact or verify outreach from Aisha by emailing [email protected] or via encrypted message at aisha_malik.01 on Signal.
Beyond the period tracker: how wearables are finally getting hormones right, and who does it best. From temperature-sensing smart rings to menopause tracking on your wrist, wearables are finally taking hormonal health seriously 11 October 2026 / 18:50 BST For years, women's health on a fitness tracker meant a glorified period calendar. You logged your flow manually (requiring you to remember to do so), and you'd get a vague prediction for the following month (only helpful for those with regular cycles). That was about it. The same device would happily tell you your VO2 Max to two decimal places, but when it came to correlating your energy score with your cycle phase, you'd be out of luck. That's finally starting to change (albeit slowly). It hasn't happened because of a single breakthrough, but because several pieces of the puzzle are falling into place. Wearable sensors can now detect subtle overnight temperature shifts, and companies are using AI models trained specifically on reproductive health data rather than treating female health tracking as an afterthought. There's still work to do, but wearables are moving in the right direction for tracking female health and hormonal changes. Here are the leaders and what they offer. Oura. For any woman who has used the Natural Cycles app, it will likely come as no surprise that Oura is one of the companies setting the pace in female cycle tracking. It was the first wearable to partner with the FDA-cleared birth control app, allowing users to wear its smart rings for temperature input instead of using a basal thermometer every morning before getting out of bed. Other wearables also now support Natural Cycles integration, but Oura pipped them all to the post in 2022. This year, ahead of the Oura Ring 5 launch, the Finnish company introduced Menopause Insights. It centres on the Menopause Impact Scale, a questionnaire developed by Oura to measure how 22 symptoms affect quality of life and daily functioning. Oura combines your answers with your long-term biometric data to explain your results, show how symptoms correlate with trends such as HRV and sleep disturbances, and track changes over time. For cycle tracking, Oura also released an AI model trained specifically on reproductive health data and added the option to tell the app which birth control method you are using (hormonal or non-hormonal), if any. By entering this information, the app takes it into account to deliver more accurate and relevant insights. Oura uses temperature data to predict ovulation, helping not only to tell you what stage of your cycle you are in and what that might mean for metrics like your heart rate and HRV, but also to identify which days you're most likely to conceive. It also has an AI-powered advisor, allowing users to ask questions about their data and cycle to help them make sense of the information being presented to them. Ultrahuman. Ultrahuman takes a similar approach to Oura, continuously tracking temperature with its smart rings - Ring Air and Ring Pro - to provide insights into the female cycle. Unlike Oura, which has a monthly subscription, Ultrahuman doesn't require one. However, there is the option to add paid PowerPlugs, including the Cycle & Ovulation Pro, which costs $3.99 a month. The free cycle tracking included with Ultrahuman uses temperature to predict ovulation and determine your cycle phase, with helpful insights to explain what that might mean. The Cycle & Ovulation Pro PowerPlug takes this several steps further. It uses the same sensors as the free version but, following the company's acquisition of viO HealthTech (a medical device company behind the OvuSense fertility monitor), adapts viO's temperature-sensing algorithm, developed over 15 years and trained on more than 260,000 cycles collected with medical-grade sensors. Ultrahuman says Pro confirms ovulation with more than 90 per cent accuracy, based on its own testing against LH and progesterone rises. It's aimed at people whose cycles don't follow the textbook 28-day cycle, including those with PCOS or endometriosis, though it isn't FDA-cleared or intended for contraception. Another notable feature is Cycle Flags, which analyses temperature data for patterns rather than making single-cycle predictions: for example, consistently early or late ovulation, a shortened luteal phase, or cycles where ovulation doesn't appear to occur at all. None of that is diagnostic - Ultrahuman is explicit that Pro is a wellness tool, not a substitute for clinical testing - but surfacing a recurring pattern over several months could be a helpful piece of information to bring to a doctor, rather than something you'd notice from period-diary logging alone. Whoop. Historically the most performance-obsessed of the bunch, Whoop leans more on lab work than its rivals. Its Hormonal Symptom Insights and Predictions, announced in March of this year, build a personalised model of your cycle from your physiological data and history. The model adapts over time, widening or narrowing its forecast as it learns how variable your cycles are. Whoop says it accounts for irregular cycles, perimenopause and hormonal birth control. Whoop Advanced Labs adds a Women's Health panel of 81 biomarkers, including 11 female-specific ones: AMH, progesterone, prolactin, thyroid markers, leptin, B12, folate, magnesium and phosphorus. Testing is conducted at Quest Diagnostics locations, with results reviewed by a licensed clinician. The panel is sold separately and is US-only, so unfortunately for anyone this side of the pond, you can't benefit from it just yet. For those in the US, results are tied back to your cycle, with reference ranges matched to your cycle phase and sorted into optimal, sufficient or out of range. Whoop says this helps with perimenopause, thyroid function and nutrient levels, which it says standard testing often under-measures. It has published a white paper on its modelling, so if you fancy some bedtime reading. Apple Watch. Apple takes a slightly more cautious approach than the others I've mentioned so far. Its Cycle Tracking app (also in the Health app on iPhone) logs periods, symptoms, spotting and basal body temperature, then predicts your next period and a six-day fertile window. Predictions rely on what you log, and the fertile window uses the traditional calendar method. Heart rate data from the Watch, enabled by default, further refines predictions, and on compatible models, overnight wrist temperature is used to estimate ovulation retrospectively, improving predictions. Menopause support has also been introduced with the latest software - iOS 27 and watchOS 27. For users aged 40 and over, Cycle Tracking can notify you when your logged cycles suggest perimenopause. In the Health app on iPhone, you can then log perimenopause or menopause and track symptoms such as hot flushes, night sweats and sleep changes. Once menopause is logged, predictions and fertile window estimates are disabled. None of the devices mentioned above measure hormones directly. They infer hormone levels from temperature, heart rate and HRV, and illness, alcohol, travel or a bad night's sleep can all muddy the signal. A wearable can't always distinguish ovulation from a rough night, which is why pretty much every brand stresses that its features are for wellness, not diagnosis. The next step may be dedicated hormone monitoring. Clair Health is developing a wearable that it says reads hormone patterns from more than 130 physiological signals, using machine learning trained on paired hormone data. That's still inference rather than direct measurement, and it isn't on sale yet, with devices due in January 2027. For now, then, what's above is what is available. They might not be perfect, but it's a lot better than what it was even a couple of years ago, so Stuff is on the right track. Britta O'Boyle About. Britta has covered the consumer tech industry since 2012. Her specialties include smartphones, smart home, speakers and wearables.